1. You Are At:
  2. English News
  3. India
  4. Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant

Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant

Sputnik V will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus to other vaccine manufacturers, the Russian vaccine maker announced on Thursday.

India TV News Desk India TV News Desk
New Delhi Updated on: June 17, 2021 20:04 IST
A healthcare worker prepares a dose of the Sputnik V
Image Source : AP

A healthcare worker prepares a dose of the Sputnik V vaccine for COVID-19.

Sputnik V will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus to other vaccine manufacturers, the Russian vaccine maker announced on Thursday.

Meanwhile, Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi.

Presently it being a limited pilot phase, registration on CoWIN is not open for the public and will become open once the commercial launch is commenced, a press release from Dr Reddy's said on Wednesday.

The limited pilot soft-launch of the Sputnik V vaccine in India that was initiated by Dr Reddy's in Hyderabad on May 14 has now been successfully scaled up to other cities such as Visakhapatnam, Bengaluru, Mumbai, Kolkata and Delhi, Baddi, Chennai, Miryalaguda and Kolhapur with more cities to follow in the next few days, Dr Reddy said in an update.

Dr Reddys Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of SputnikVin India.

ALSO READSerum institute to start clinical trials of Novavax shot for children in July: Sources

The Indian drug-maker recently received nearly three million doses of Sputnik V. The pilot has allowed Dr Reddys to test the cold storage arrangements of -18C temperature in the cities, CoWIN integration, track and trace and other logistical arrangements ahead of the commercial launch, the release said.

The limited pilot phase is currently in its final leg as we gear up to ensure a smooth commercial launch, it said.

Adequate number of cold chain units is being deployed and the last mail arrangement is being validated at every partner hospital to ensure seamless storage and handling of the vaccine, Dr Reddys said.

ALSO READThird wave of Covid-19 unlikely to affect children much: AIIMS survey

Latest India News

Write a comment

X